Form 4 for ASTH Astrana Health, Inc.

Accepted 2023-03-13 00:00:00 ET · period of report 2020-03-04 · accession 0001250853-23-000009 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-03-13	2023-03-09	ASTH	Marsh Linda	Dir	M - OptEx	$10.00	+62.5K	62.5K	New	+$625.0K
D	2023-03-13	2020-03-04	ASTH	Marsh Linda	Dir	A - Grant	—	+62.5K	62.5K	New	—
D	2023-03-13	2023-03-09	ASTH	Marsh Linda	Dir	M - OptEx	$0.00	-62.5K	0	-100%	$0
D	2023-03-13	2020-03-04	ASTH	Marsh Linda	Dir	D - Sale to Iss	—	-62.5K	0	-100%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-03-09	M	A	62,500	$10.00	62,500	D	—	—
2	Derivative	Stock Option (right to buy)	2020-03-04	A	A	62,500	—	62,500	D	$10.00 · — to 2023-04-05	62,500 Common Stock	(F2) The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017.
3	Derivative	Stock Option (right to buy)	2023-03-09	M	D	62,500	$0.00	0	D	$10.00 · — to 2023-04-05	62,500 Common Stock	(F3) The stock options were granted on March 4, 2020 and vested and became exercisable on the date of the grant.
4	Derivative	Stock Option (right to buy)	2020-03-04	D	D	62,500	—	0	D	$10.00 · — to 2020-04-05	62,500 Common Stock	(F2) The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017.